Cargando…
Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Adoptive cell therapy is a rapidly advancing approach to cancer immunotherapy that seeks to facilitate antitumor responses by introducing potent effector cells into the tumor microenvironment. Expanded autologous T cells, particularly T cells with engineered T cell receptors (TCR) and chimeric antig...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115029/ https://www.ncbi.nlm.nih.gov/pubmed/35580928 http://dx.doi.org/10.1136/jitc-2022-004693 |